Frontiers | Recent Advances and New Biomarkers in Ulcerative Colitis - Volume II

Recent Advances and New Biomarkers in Ulcerative Colitis - Volume II

987
Total downloads
4,362
Total views and downloads

Articles

CLINICAL TRIAL

Published on 22 Jan 2025

Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study

Sumaiah J. Alarfaj
Sahar M. El-Haggar
Sahar K. Hegazy
Maha M. Maher
Monir M. Bahgat
Thanaa A. Elmasry
Sarah Alrubia
Amsha S. Alsegiani
Mostafa M. Bahaa

doi 10.3389/fmed.2024.1490178

465 views

REVIEW

Accepted on 23 Dec 2024

T helper cell 17/regulatory T cell balance regulates ulcerative colitis and the therapeutic role of natural plant components: a review

Da Zhao
Anqi Ge
Kailin Yang
Cong Yan
Xingci Liu
Yexing Yan
Moujia Hao
Junpeng Chen
Pawan Daga
2 more
Hui Cao

doi 10.3389/fmed.2024.1502849

114 views

REVIEW

Published on 02 Aug 2024

Deep mucosal healing in ulcerative colitis: how deep is better?

Xin Jin
Yan You
Gechong Ruan
Weixun Zhou
Ji Li
Jingnan Li

Deep mucosal healing in ulcerative colitis: how deep is better?

doi 10.3389/fmed.2024.1429427

1,051 views

ORIGINAL RESEARCH

Published on 12 Mar 2024

C-reactive protein-to-albumin ratio and neutrophil-to-albumin ratio for predicting response and prognosis to infliximab in ulcerative colitis

Yanyan Zhang
Feng Xu
Ya Li
Bing Chen

C-reactive protein-to-albumin ratio and neutrophil-to-albumin ratio for predicting response and prognosis to infliximab in ulcerative colitis

doi 10.3389/fmed.2024.1349070

1,452 views
4 citations

Share on

Frontiers in Medicine

Frontiers in Medicine

Gastroenterology

Impact

4,362Topic views
2,798Article views
987Article downloads